Loading…
Resilience to Injury: A New Approach to Neuroprotection?
Despite thousands of neuroprotectants demonstrating promise in preclinical trials, a neuroprotective therapeutic has yet to be approved for the treatment of acute brain injuries such as stroke or traumatic brain injury. Developing a more detailed understanding of models and populations demonstrating...
Saved in:
Published in: | Neurotherapeutics 2020-04, Vol.17 (2), p.457-474 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c474t-c15d5f30748de13cc93ace4e52839e55587eb3e0aaf8f5a2712be9ba038555c03 |
---|---|
cites | cdi_FETCH-LOGICAL-c474t-c15d5f30748de13cc93ace4e52839e55587eb3e0aaf8f5a2712be9ba038555c03 |
container_end_page | 474 |
container_issue | 2 |
container_start_page | 457 |
container_title | Neurotherapeutics |
container_volume | 17 |
creator | Singhal, Neel S. Sun, Chung-Huan Lee, Evan M. Ma, Dengke K. |
description | Despite thousands of neuroprotectants demonstrating promise in preclinical trials, a neuroprotective therapeutic has yet to be approved for the treatment of acute brain injuries such as stroke or traumatic brain injury. Developing a more detailed understanding of models and populations demonstrating “neurological resilience” in spite of brain injury can give us important insights into new translational therapies. Resilience is the process of active adaptation to a stressor. In the context of neuroprotection, models of preconditioning and unique animal models of extreme physiology (such as hibernating species) reliably demonstrate resilience in the laboratory setting. In the clinical setting, resilience is observed in young patients and can be found in those with specific genetic polymorphisms. These important examples of resilience can help transform and extend the current neuroprotective framework from simply countering the injurious cascade into one that anticipates, monitors, and optimizes patients’ physiological responses from the time of injury throughout the process of recovery. This review summarizes the underpinnings of key adaptations common to models of resilience and how this understanding can be applied to new neuroprotective approaches. |
doi_str_mv | 10.1007/s13311-020-00832-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7283435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2348795938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-c15d5f30748de13cc93ace4e52839e55587eb3e0aaf8f5a2712be9ba038555c03</originalsourceid><addsrcrecordid>eNp9kctOHDEQRa0IFB7JD2SBWmKTTYPLZWM7i6DRiJeEiBQla8vjqYYe9bQndjcRf49hCBAWrMqle-qWS5exL8APgHN9mAERoOaC15wbFLX-wLbBaFNrqe1GeVvEWgvALbaT84JzhWjNR7aFYK0WR2abmZ-U266lPlA1xOqiX4zp7ls1qa7obzVZrVL04eZBuaIxxdIOFIY29sef2Gbju0yfn-ou-3168mt6Xl_-OLuYTi7rILUc6gBqrhrkWpo5AYZg0QeSpIRBS0opo2mGxL1vTKO80CBmZGeeoyli4LjLvq99V-NsSfNA_ZB851apXfp056Jv3f9K396463jrdNkgURWDr08GKf4ZKQ9u2eZAXed7imN2AqXRVlk0Bd1_gy7imPpynhMSgCsACYUSayqkmHOi5vkzwN1DMG4djCvBuMdgnC5De6_PeB75l0QBcA3kIvXXlF52v2N7D1-_mCY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2411051141</pqid></control><display><type>article</type><title>Resilience to Injury: A New Approach to Neuroprotection?</title><source>Springer Link</source><source>PubMed Central</source><creator>Singhal, Neel S. ; Sun, Chung-Huan ; Lee, Evan M. ; Ma, Dengke K.</creator><creatorcontrib>Singhal, Neel S. ; Sun, Chung-Huan ; Lee, Evan M. ; Ma, Dengke K.</creatorcontrib><description>Despite thousands of neuroprotectants demonstrating promise in preclinical trials, a neuroprotective therapeutic has yet to be approved for the treatment of acute brain injuries such as stroke or traumatic brain injury. Developing a more detailed understanding of models and populations demonstrating “neurological resilience” in spite of brain injury can give us important insights into new translational therapies. Resilience is the process of active adaptation to a stressor. In the context of neuroprotection, models of preconditioning and unique animal models of extreme physiology (such as hibernating species) reliably demonstrate resilience in the laboratory setting. In the clinical setting, resilience is observed in young patients and can be found in those with specific genetic polymorphisms. These important examples of resilience can help transform and extend the current neuroprotective framework from simply countering the injurious cascade into one that anticipates, monitors, and optimizes patients’ physiological responses from the time of injury throughout the process of recovery. This review summarizes the underpinnings of key adaptations common to models of resilience and how this understanding can be applied to new neuroprotective approaches.</description><identifier>ISSN: 1933-7213</identifier><identifier>ISSN: 1878-7479</identifier><identifier>EISSN: 1878-7479</identifier><identifier>DOI: 10.1007/s13311-020-00832-7</identifier><identifier>PMID: 31997268</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adaptation ; Adaptation, Physiological ; Animal models ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Brain Diseases ; Clinical trials ; Humans ; Neurobiology ; Neurology ; Neuroprotection ; Neurosciences ; Neurosurgery ; Patients ; Review ; Traumatic brain injury</subject><ispartof>Neurotherapeutics, 2020-04, Vol.17 (2), p.457-474</ispartof><rights>The American Society for Experimental NeuroTherapeutics, Inc. 2020</rights><rights>The American Society for Experimental NeuroTherapeutics, Inc. 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-c15d5f30748de13cc93ace4e52839e55587eb3e0aaf8f5a2712be9ba038555c03</citedby><cites>FETCH-LOGICAL-c474t-c15d5f30748de13cc93ace4e52839e55587eb3e0aaf8f5a2712be9ba038555c03</cites><orcidid>0000-0003-1605-4444</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283435/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283435/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,733,786,790,891,27957,27958,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31997268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singhal, Neel S.</creatorcontrib><creatorcontrib>Sun, Chung-Huan</creatorcontrib><creatorcontrib>Lee, Evan M.</creatorcontrib><creatorcontrib>Ma, Dengke K.</creatorcontrib><title>Resilience to Injury: A New Approach to Neuroprotection?</title><title>Neurotherapeutics</title><addtitle>Neurotherapeutics</addtitle><addtitle>Neurotherapeutics</addtitle><description>Despite thousands of neuroprotectants demonstrating promise in preclinical trials, a neuroprotective therapeutic has yet to be approved for the treatment of acute brain injuries such as stroke or traumatic brain injury. Developing a more detailed understanding of models and populations demonstrating “neurological resilience” in spite of brain injury can give us important insights into new translational therapies. Resilience is the process of active adaptation to a stressor. In the context of neuroprotection, models of preconditioning and unique animal models of extreme physiology (such as hibernating species) reliably demonstrate resilience in the laboratory setting. In the clinical setting, resilience is observed in young patients and can be found in those with specific genetic polymorphisms. These important examples of resilience can help transform and extend the current neuroprotective framework from simply countering the injurious cascade into one that anticipates, monitors, and optimizes patients’ physiological responses from the time of injury throughout the process of recovery. This review summarizes the underpinnings of key adaptations common to models of resilience and how this understanding can be applied to new neuroprotective approaches.</description><subject>Adaptation</subject><subject>Adaptation, Physiological</subject><subject>Animal models</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain Diseases</subject><subject>Clinical trials</subject><subject>Humans</subject><subject>Neurobiology</subject><subject>Neurology</subject><subject>Neuroprotection</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Patients</subject><subject>Review</subject><subject>Traumatic brain injury</subject><issn>1933-7213</issn><issn>1878-7479</issn><issn>1878-7479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kctOHDEQRa0IFB7JD2SBWmKTTYPLZWM7i6DRiJeEiBQla8vjqYYe9bQndjcRf49hCBAWrMqle-qWS5exL8APgHN9mAERoOaC15wbFLX-wLbBaFNrqe1GeVvEWgvALbaT84JzhWjNR7aFYK0WR2abmZ-U266lPlA1xOqiX4zp7ls1qa7obzVZrVL04eZBuaIxxdIOFIY29sef2Gbju0yfn-ou-3168mt6Xl_-OLuYTi7rILUc6gBqrhrkWpo5AYZg0QeSpIRBS0opo2mGxL1vTKO80CBmZGeeoyli4LjLvq99V-NsSfNA_ZB851apXfp056Jv3f9K396463jrdNkgURWDr08GKf4ZKQ9u2eZAXed7imN2AqXRVlk0Bd1_gy7imPpynhMSgCsACYUSayqkmHOi5vkzwN1DMG4djCvBuMdgnC5De6_PeB75l0QBcA3kIvXXlF52v2N7D1-_mCY</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Singhal, Neel S.</creator><creator>Sun, Chung-Huan</creator><creator>Lee, Evan M.</creator><creator>Ma, Dengke K.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1605-4444</orcidid></search><sort><creationdate>20200401</creationdate><title>Resilience to Injury: A New Approach to Neuroprotection?</title><author>Singhal, Neel S. ; Sun, Chung-Huan ; Lee, Evan M. ; Ma, Dengke K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-c15d5f30748de13cc93ace4e52839e55587eb3e0aaf8f5a2712be9ba038555c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adaptation</topic><topic>Adaptation, Physiological</topic><topic>Animal models</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain Diseases</topic><topic>Clinical trials</topic><topic>Humans</topic><topic>Neurobiology</topic><topic>Neurology</topic><topic>Neuroprotection</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Patients</topic><topic>Review</topic><topic>Traumatic brain injury</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singhal, Neel S.</creatorcontrib><creatorcontrib>Sun, Chung-Huan</creatorcontrib><creatorcontrib>Lee, Evan M.</creatorcontrib><creatorcontrib>Ma, Dengke K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singhal, Neel S.</au><au>Sun, Chung-Huan</au><au>Lee, Evan M.</au><au>Ma, Dengke K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resilience to Injury: A New Approach to Neuroprotection?</atitle><jtitle>Neurotherapeutics</jtitle><stitle>Neurotherapeutics</stitle><addtitle>Neurotherapeutics</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>17</volume><issue>2</issue><spage>457</spage><epage>474</epage><pages>457-474</pages><issn>1933-7213</issn><issn>1878-7479</issn><eissn>1878-7479</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><notes>ObjectType-Review-1</notes><abstract>Despite thousands of neuroprotectants demonstrating promise in preclinical trials, a neuroprotective therapeutic has yet to be approved for the treatment of acute brain injuries such as stroke or traumatic brain injury. Developing a more detailed understanding of models and populations demonstrating “neurological resilience” in spite of brain injury can give us important insights into new translational therapies. Resilience is the process of active adaptation to a stressor. In the context of neuroprotection, models of preconditioning and unique animal models of extreme physiology (such as hibernating species) reliably demonstrate resilience in the laboratory setting. In the clinical setting, resilience is observed in young patients and can be found in those with specific genetic polymorphisms. These important examples of resilience can help transform and extend the current neuroprotective framework from simply countering the injurious cascade into one that anticipates, monitors, and optimizes patients’ physiological responses from the time of injury throughout the process of recovery. This review summarizes the underpinnings of key adaptations common to models of resilience and how this understanding can be applied to new neuroprotective approaches.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>31997268</pmid><doi>10.1007/s13311-020-00832-7</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0003-1605-4444</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1933-7213 |
ispartof | Neurotherapeutics, 2020-04, Vol.17 (2), p.457-474 |
issn | 1933-7213 1878-7479 1878-7479 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7283435 |
source | Springer Link; PubMed Central |
subjects | Adaptation Adaptation, Physiological Animal models Animals Biomedical and Life Sciences Biomedicine Brain Diseases Clinical trials Humans Neurobiology Neurology Neuroprotection Neurosciences Neurosurgery Patients Review Traumatic brain injury |
title | Resilience to Injury: A New Approach to Neuroprotection? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T00%3A19%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resilience%20to%20Injury:%20A%20New%20Approach%20to%20Neuroprotection?&rft.jtitle=Neurotherapeutics&rft.au=Singhal,%20Neel%20S.&rft.date=2020-04-01&rft.volume=17&rft.issue=2&rft.spage=457&rft.epage=474&rft.pages=457-474&rft.issn=1933-7213&rft.eissn=1878-7479&rft_id=info:doi/10.1007/s13311-020-00832-7&rft_dat=%3Cproquest_pubme%3E2348795938%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-c15d5f30748de13cc93ace4e52839e55587eb3e0aaf8f5a2712be9ba038555c03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2411051141&rft_id=info:pmid/31997268&rfr_iscdi=true |